The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The new online Learning Center with new content can still be found under the “Training” folder on ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...